Clinical Trial Update: A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of OMX-0407 in patients with previously treated solid tumors that cannot be surgically removed has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• OMX-0407

Snippet

Sponsor: iOmx Therapeutics AG | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED